# Normal Saline Infusion for Stroke After Intravenous Thrombolysis

> **NCT05993078** · PHASE2 · COMPLETED · sponsor: **Tianjin Medical University General Hospital** · enrollment: 241 (actual)

## Conditions studied

- Brain Infarct

## Interventions

- **DRUG:** 0.9% NaCl 2000ml
- **DRUG:** 0.9% NaCl 200-400ml

## Key facts

- **NCT ID:** NCT05993078
- **Lead sponsor:** Tianjin Medical University General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-12-20
- **Final completion:** 2025-01-08
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2025-03-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05993078

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05993078, "Normal Saline Infusion for Stroke After Intravenous Thrombolysis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05993078. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*